Latest round: IPO. Kevin Ali is the Chief Executive Officer and Board member at Organon, a global healthcare company focused on improving women's health.
Kevin Ali is the Chief Executive Officer and Board member at Organon, a global healthcare company focused on improving women's health. He helped lead the formation of Organon as a spin-off from Merck & Co. Under his leadership, Organon has established itself as a leading women's health company with operations in over 60 countries. Prior to Organon, Ali spent more than three decades at Merck, holding various leadership roles including president of Merck’s international business.
Full founder directory · Investor directory · Company funding database · Fundraising library